Marinomed Biotech AG

MARI.VI · VIE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-€7-€6-€6
Dep. & Amort.€1€1€1
Deferred Tax€0€0€0
Stock-Based Comp.€0€0€0
Change in WC€1-€0-€1
Other Non-Cash€1€1€1
Operating Cash Flow-€5-€5-€5
Investing Activities
PP&E Inv.€0-€0-€1
Net Acquisitions€0€0€0
Inv. Purchases€0€0€0
Inv. Sales/Matur.€0€0€0
Other Inv. Act.-€0€0€0
Investing Cash Flow-€0-€0-€1
Financing Activities
Debt Repay.-€1€8€2
Stock Issued€0€0€0
Stock Repurch.€0€0€0
Dividends Paid€0€0€0
Other Fin. Act.-€0-€0-€0
Financing Cash Flow-€1€8€2
Forex Effect€0€0€0
Net Chg. in Cash-€6€2-€3
Supplemental Information
Beg. Cash€8€6€9
End Cash€3€8€6
Free Cash Flow-€5-€5-€6
Marinomed Biotech AG (MARI.VI) Financial Statements & Key Stats | AlphaPilot